Here, we list the TRAEs caused by PD-1 and PD-L1 inhibitors in the treatment of NSCLC in Tables 1, 2, respectively, both monotherapy and combination therapy are included. The gene discussed is CD274; the disease is non-small cell lung carcinoma.